/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Equillium Inc Share Price Today: Live Updates & Key Insights

Equillium Inc share price today is $2.495, up -7.43%. The stock opened at $2.66 against the previous close of $2.69, with an intraday high of $2.66 and low of $2.49.

Equillium Inc Share Price Chart

style
pb-0

Equillium Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Equillium Inc Share Price Performance

$2.495 -0.0743(-7.43%) EQ at 27 Jul 2026 02:53 PM Biotechnology
Lowest Today 2.49
Highest Today 2.66
Today’s Open 2.66
Prev. Close 2.69
52 Week High 3.54
52 Week Low 0.37
Day’s Range: Low 2.49 High 2.66
52-Week Range: Low 0.37 High 3.54
1 day return -
1 Week return +1.83
1 month return -17.38
3 month return +21.7
6 month return +106.19
1 year return +482.94
3 year return +236.66
5 year return -57.2
10 year return -

Equillium Inc Institutional Holdings

HHG PLC 10.27

Adage Capital Partners Gp LLC 8.43

Decheng Capital LLC 7.03

ADAR1 Capital Management LLC 5.89

abrdn Life Sciences Investors 5.74

Woodline Partners LP 5.54

Aberdeen Group PLC 5.30

RA Capital Management, LLC 4.90

Vanguard Group Inc 3.04

Vanguard Capital Management, LLC 2.82

Balyasny Asset Management LLC 2.59

Eversept Partners, LP 2.37

Vanguard Total Stock Mkt Idx Inv 2.22

Affinity Asset Advisors, LLC 1.94

Renaissance Technologies Corp 1.04

Diadema Partners LP 0.69

Hudson Bay Capital Management LP 0.68

Geode Capital Management, LLC 0.60

Vanguard Institutional Extnd Mkt Idx Tr 0.59

Ikarian Capital, LLC 0.48

CANTOR FITZGERALD, L. P. 0.42

Two Sigma Investments LLC 0.39

Jane Street Group LLC 0.35

Fidelity Extended Market Index 0.26

iShares Micro-Cap ETF 0.23

Blackrock Extended Mkt Fund CF 0.20

Extended Equity Market Fund B 0.20

Extended Equity Market Fund E 0.20

BlackRock Extended Equity Market Fund K 0.17

Fidelity Total Market Index 0.09

Fidelity Series Total Market Index 0.08

Spartan Extended Market Index Pool F 0.07

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Index Fund - Lending 0.06

Fidelity Nasdaq Composite Index 0.06

Invesco NASDAQ Future Gen 200 ETF 0.06

Vanguard Instl Ttl Stck Mkt Index Trust 0.06

NT Ext Equity Mkt Index Fund - NL 0.05

Avantis US Small Cap Equity ETF 0.04

Vanguard Balanced Index Inv 0.04

Equillium Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 2

Sell: 0

Strong Sell: 0

Equillium Inc Fundamentals

Market Cap 170.08 M

PB Ratio 2.9335

PE Ratio 0.0

Enterprise Value 113.88 M

Total Assets 31.89 M

Volume 197970

Equillium Inc Company Financials

Annual Revenue FY23:42632000 42.6M, FY22:15759000 15.8M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:15759000 15.8M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-8220000 -8.2M, FY22:-107707000 -107.7M, FY21:-38980000 -39.0M, FY20:-29768000 -29.8M, FY19:-25577000 -25.6M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:12161000 12.2M

Quarterly Profit Q1/2026:-24000 -0.0M, Q3/2025:-28000 -0.0M, Q2/2025:-32000 -0.0M, Q1/2025:-33000 -0.0M, Q3/2024:12161000 12.2M

Quarterly Net worth Q1/2026:-5311000 -5.3M, Q3/2025:-4230000 -4.2M, Q2/2025:-5739000 -5.7M, Q1/2025:-8654000 -8.7M, Q3/2024:-7000 -0.0M

About Equillium Inc & investment objective

Company Information Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO Mr. Bruce D. Steel

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Equillium Inc FAQs

What is the share price of Equillium Inc today?

The current share price of Equillium Inc is $2.495.

Can I buy Equillium Inc shares in India?

Yes, Indian investors can buy Equillium Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Equillium Inc shares in India?

You can easily invest in Equillium Inc shares from India by:

Can I buy fractional shares of Equillium Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Equillium Inc?

Equillium Inc has a market cap of $170.08 M.

In which sector does Equillium Inc belong?

Equillium Inc operates in the Biotechnology sector.

What documents are required to invest in Equillium Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Equillium Inc?

The PE ratio of Equillium Inc is N/A and the PB ratio is 2.93.